FDA clearance for Binax Bacterial Meningitis
Binax have announced an additional cleared application for the patented Streptococcus pneumoniae Antigen Test.
The test can be used on CSF for the detection of bacterial meningitis caused by S. pneumoniae
Binax recently announced an exclusive distribution partnership with Remel Inc to provide rapid tests to hospital and clinical reference laboratories in the USA.
Source: Binax, Inc. [USA]
Now part of Alere, Inc View company information
Posted: December 15, 2001
[will open your email client]